These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 25385064)

  • 1. C3d adjuvant effects are mediated through the activation of C3d-specific autoreactive T cells.
    De Groot AS; Ross TM; Levitz L; Messitt TJ; Tassone R; Boyle CM; Vincelli AJ; Moise L; Martin W; Knopf PM
    Immunol Cell Biol; 2015 Feb; 93(2):189-97. PubMed ID: 25385064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel function of complement C3d as an autologous helper T-cell target.
    Knopf PM; Rivera DS; Hai SH; McMurry J; Martin W; De Groot AS
    Immunol Cell Biol; 2008; 86(3):221-5. PubMed ID: 18180801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Helper T cell epitope-mapping reveals MHC-peptide binding affinities that correlate with T helper cell responses to pneumococcal surface protein A.
    Singh R; Singh S; Sharma PK; Singh UP; Briles DE; Hollingshead SK; Lillard JW
    PLoS One; 2010 Feb; 5(2):e9432. PubMed ID: 20195541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A minimum CR2 binding domain of C3d enhances immunity following vaccination.
    Bower JF; Ross TM
    Adv Exp Med Biol; 2006; 586():249-64. PubMed ID: 16893077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement component C3d-antigen complexes can either augment or inhibit B lymphocyte activation and humoral immunity in mice depending on the degree of CD21/CD19 complex engagement.
    Lee Y; Haas KM; Gor DO; Ding X; Karp DR; Greenspan NS; Poe JC; Tedder TF
    J Immunol; 2005 Dec; 175(12):8011-23. PubMed ID: 16339538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4+ T cell epitopes of FliC conserved between strains of Burkholderia: implications for vaccines against melioidosis and cepacia complex in cystic fibrosis.
    Musson JA; Reynolds CJ; Rinchai D; Nithichanon A; Khaenam P; Favry E; Spink N; Chu KK; De Soyza A; Bancroft GJ; Lertmemongkolchai G; Maillere B; Boyton RJ; Altmann DM; Robinson JH
    J Immunol; 2014 Dec; 193(12):6041-9. PubMed ID: 25392525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of complement receptor type 2 and endogenous complement in the humoral immune response to conjugates of complement C3d and pneumococcal serotype 14 capsular polysaccharide.
    Mitsuyoshi JK; Hu Y; Test ST
    Infect Immun; 2005 Nov; 73(11):7311-6. PubMed ID: 16239528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epitope mapping using the X-ray crystallographic structure of complement receptor type 2 (CR2)/CD21: identification of a highly inhibitory monoclonal antibody that directly recognizes the CR2-C3d interface.
    Guthridge JM; Young K; Gipson MG; Sarrias MR; Szakonyi G; Chen XS; Malaspina A; Donoghue E; James JA; Lambris JD; Moir SA; Perkins SJ; Holers VM
    J Immunol; 2001 Nov; 167(10):5758-66. PubMed ID: 11698449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional characterization of ocular-derived human alphaherpesvirus cross-reactive CD4 T cells.
    Ouwendijk WJ; Geluk A; Smits SL; Getu S; Osterhaus AD; Verjans GM
    J Immunol; 2014 Apr; 192(8):3730-9. PubMed ID: 24623134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement-mediated activation of the adaptive immune responses: role of C3d in linking the innate and adaptive immunity.
    Toapanta FR; Ross TM
    Immunol Res; 2006; 36(1-3):197-210. PubMed ID: 17337780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of HLA DR7-restricted epitopes from human telomerase reverse transcriptase recognized by CD4+ T-helper cells.
    Schroers R; Huang XF; Hammer J; Zhang J; Chen SY
    Cancer Res; 2002 May; 62(9):2600-5. PubMed ID: 11980655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of promiscuous KIF20A long peptides bearing both CD4+ and CD8+ T-cell epitopes: KIF20A-specific CD4+ T-cell immunity in patients with malignant tumor.
    Tomita Y; Yuno A; Tsukamoto H; Senju S; Kuroda Y; Hirayama M; Irie A; Kawahara K; Yatsuda J; Hamada A; Jono H; Yoshida K; Tsunoda T; Kohrogi H; Yoshitake Y; Nakamura Y; Shinohara M; Nishimura Y
    Clin Cancer Res; 2013 Aug; 19(16):4508-20. PubMed ID: 23714729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The adenovirus capsid protein hexon contains a highly conserved human CD4+ T-cell epitope.
    Olive M; Eisenlohr L; Flomenberg N; Hsu S; Flomenberg P
    Hum Gene Ther; 2002 Jul; 13(10):1167-78. PubMed ID: 12133270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential capacity of T cell priming in naive donors of promiscuous CD4+ T cell epitopes of HCV NS3 and Core proteins.
    Castelli FA; Leleu M; Pouvelle-Moratille S; Farci S; Zarour HM; Andrieu M; Auriault C; Ménez A; Georges B; Maillere B
    Eur J Immunol; 2007 Jun; 37(6):1513-23. PubMed ID: 17492804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of novel helper epitope peptides of Survivin cancer-associated antigen applicable to developing helper/killer-hybrid epitope long peptide cancer vaccine.
    Ohtake J; Ohkuri T; Togashi Y; Kitamura H; Okuno K; Nishimura T
    Immunol Lett; 2014 Sep; 161(1):20-30. PubMed ID: 24794408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Arthritis-Suppressive and Treg Cell-Inducing CD4+ T Cell Epitope Is Functional in the Context of HLA-Restricted T Cell Responses.
    de Wolf C; van der Zee R; den Braber I; Glant T; Maillère B; Favry E; van Lummel M; Koning F; Hoek A; Ludwig I; van Eden W; Broere F
    Arthritis Rheumatol; 2016 Mar; 68(3):639-47. PubMed ID: 26414917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the Immune Complex-Bound Complement C3d Ligand as a Novel Therapy for Lupus.
    Kulik L; Laskowski J; Renner B; Woolaver R; Zhang L; Lyubchenko T; You Z; Thurman JM; Holers VM
    J Immunol; 2019 Dec; 203(12):3136-3147. PubMed ID: 31732528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and characterization of a WT1 (Wilms Tumor Gene) protein-derived HLA-DRB1*0405-restricted 16-mer helper peptide that promotes the induction and activation of WT1-specific cytotoxic T lymphocytes.
    Fujiki F; Oka Y; Tsuboi A; Kawakami M; Kawakatsu M; Nakajima H; Elisseeva OA; Harada Y; Ito K; Li Z; Tatsumi N; Sakaguchi N; Fujioka T; Masuda T; Yasukawa M; Udaka K; Kawase I; Oji Y; Sugiyama H
    J Immunother; 2007 Apr; 30(3):282-93. PubMed ID: 17414319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient presentation of known HLA class II-restricted MAGE-A3 epitopes by dendritic cells electroporated with messenger RNA encoding an invariant chain with genetic exchange of class II-associated invariant chain peptide.
    Bonehill A; Heirman C; Tuyaerts S; Michiels A; Zhang Y; van der Bruggen P; Thielemans K
    Cancer Res; 2003 Sep; 63(17):5587-94. PubMed ID: 14500399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C3d adjuvant activity is reduced by altering residues involved in the electronegative binding of C3d to CR2.
    Toapanta FR; DeAlmeida DR; Dunn MD; Ross TM
    Immunol Lett; 2010 Mar; 129(1):32-8. PubMed ID: 20064559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.